A New Reversible and Potent P2Y12 Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial
Crossref DOI link: https://doi.org/10.1007/s40261-014-0236-8
Published Online: 2014-10-21
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Baldoni, Daniela
Bruderer, Shirin
Krause, Andreas
Gutierrez, Marcello
Gueret, Pierre
Astruc, BĂ©atrice
Dingemanse, Jasper
Text and Data Mining valid from 2014-10-21